{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001700208,0.0003595098,0.00181651,0.0001733919,0.00003286616,0.00001127663,0.0001936689,0.0002372781,0.0000884835],"category_scores_gemma":[0.00001668293,0.0002385182,0.0003606473,0.0003609871,0.0001116751,0.00004664743,0.00004376422,0.000368658,0.00001176878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002532485,"about_ca_system_score_gemma":0.001300595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001507657,"about_ca_topic_score_gemma":0.000199986,"domain_scores_codex":[0.9979218,0.00006403841,0.0009522676,0.0005053582,0.0002573578,0.0002991466],"domain_scores_gemma":[0.9986116,0.0001796315,0.0004965313,0.0004896022,0.00009171938,0.0001309032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005453591,0.0009253531,0.01695101,0.01969946,0.0004202751,0.0001295113,0.001573378,0.000007215901,4.345445e-7,0.00002260513,0.003274092,0.9569421],"study_design_scores_gemma":[0.003196487,0.0002817439,0.00173219,0.03975999,0.003413501,0.00001514278,0.00020517,0.00001307751,0.000008889143,0.000001545915,0.950982,0.0003902106],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002232411,0.9795076,0.00001969594,0.00005463032,0.000295468,0.00191151,0.00008108901,0.00002504519,0.01587254],"genre_scores_gemma":[0.001374816,0.990953,0.0008837573,0.00007655138,0.0002504053,0.0007016641,0.0001697343,0.00006649225,0.005523578],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9565519,"threshold_uncertainty_score":0.972649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03141548310013683,"score_gpt":0.4158838494868783,"score_spread":0.3844683663867415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}